IN2014MU00815A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00815A
IN2014MU00815A IN815MU2014A IN2014MU00815A IN 2014MU00815 A IN2014MU00815 A IN 2014MU00815A IN 815MU2014 A IN815MU2014 A IN 815MU2014A IN 2014MU00815 A IN2014MU00815 A IN 2014MU00815A
Authority
IN
India
Prior art keywords
stem cells
cancer stem
compositions
methods
proliferation
Prior art date
Application number
Other languages
English (en)
Inventor
Srivastava Sangeeta
Athavale Maithili
Shukre Kedar
More Gayatri
Original Assignee
Godavari Biorefineries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Godavari Biorefineries Ltd filed Critical Godavari Biorefineries Ltd
Priority to AU2015228386A priority Critical patent/AU2015228386A1/en
Priority to JP2016556878A priority patent/JP2017507969A/ja
Priority to MX2016011675A priority patent/MX2016011675A/es
Priority to PCT/IN2015/050020 priority patent/WO2015136557A2/en
Priority to US15/125,323 priority patent/US20180169100A1/en
Priority to IN815MU2014 priority patent/IN2014MU00815A/en
Priority to EP15761397.7A priority patent/EP3116867A4/en
Priority to CA2941703A priority patent/CA2941703A1/en
Publication of IN2014MU00815A publication Critical patent/IN2014MU00815A/en
Priority to IL247723A priority patent/IL247723A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IN815MU2014 2014-03-11 2015-03-11 IN2014MU00815A (pt)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AU2015228386A AU2015228386A1 (en) 2014-03-11 2015-03-11 Cancer stem cell targeting compounds
JP2016556878A JP2017507969A (ja) 2014-03-11 2015-03-11 がん幹細胞標的化合物
MX2016011675A MX2016011675A (es) 2014-03-11 2015-03-11 Compuestos dirigidos a las celulas madre de cancer.
PCT/IN2015/050020 WO2015136557A2 (en) 2014-03-11 2015-03-11 Cancer stem cell targeting compounds
US15/125,323 US20180169100A1 (en) 2014-03-11 2015-03-11 Cancer Stem Cell Targeting Compounds
IN815MU2014 IN2014MU00815A (pt) 2014-03-11 2015-03-11
EP15761397.7A EP3116867A4 (en) 2014-03-11 2015-03-11 Cancer stem cell targeting compounds
CA2941703A CA2941703A1 (en) 2014-03-11 2015-03-11 Cancer stem cell targeting compounds
IL247723A IL247723A0 (en) 2014-03-11 2016-09-08 Compounds that target cancer stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN815MU2014 IN2014MU00815A (pt) 2014-03-11 2015-03-11

Publications (1)

Publication Number Publication Date
IN2014MU00815A true IN2014MU00815A (pt) 2015-09-25

Family

ID=54072550

Family Applications (1)

Application Number Title Priority Date Filing Date
IN815MU2014 IN2014MU00815A (pt) 2014-03-11 2015-03-11

Country Status (9)

Country Link
US (1) US20180169100A1 (pt)
EP (1) EP3116867A4 (pt)
JP (1) JP2017507969A (pt)
AU (1) AU2015228386A1 (pt)
CA (1) CA2941703A1 (pt)
IL (1) IL247723A0 (pt)
IN (1) IN2014MU00815A (pt)
MX (1) MX2016011675A (pt)
WO (1) WO2015136557A2 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ546044A (en) * 2003-08-29 2009-09-25 Vernalis Cambridge Ltd Pyrimidothiophene compounds
GB0416168D0 (en) * 2004-07-20 2004-08-18 Vernalis Cambridge Ltd Pyrmidothiophene compounds
US20100227853A1 (en) * 2008-04-18 2010-09-09 Trustees Of Boston College Inhibitors of cyclic amp phosphodiesterases
ES2363358B1 (es) * 2009-04-03 2012-06-21 FUNDACIÓ INSTITUT DE RECERCA HOSPITAL UNIVERSITARI VALL D'HEBRON (Titular al Agentes terapéuticos para el tratamiento de enfermedades asociadas con una proliferación celular indeseable.
WO2011029054A1 (en) * 2009-09-04 2011-03-10 The Regents Of The University Of Michigan Compositions and methods for treatment of leukemia

Also Published As

Publication number Publication date
EP3116867A2 (en) 2017-01-18
AU2015228386A1 (en) 2016-09-22
WO2015136557A9 (en) 2022-05-27
EP3116867A4 (en) 2017-10-18
CA2941703A1 (en) 2015-09-17
IL247723A0 (en) 2016-11-30
WO2015136557A3 (en) 2015-11-12
MX2016011675A (es) 2016-12-14
US20180169100A1 (en) 2018-06-21
JP2017507969A (ja) 2017-03-23
WO2015136557A2 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
PH12017500660A1 (en) Novel compositions, uses and methods for making them
EA201891200A1 (ru) Композиции, содержащие бактериальные штаммы
MX2020005213A (es) Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos.
NZ735998A (en) Heterocyclic compounds as lsd1 inhibitors
MX2018006217A (es) Agonistas del receptor de apelina y metodos de uso.
PH12015502028A1 (en) Ido inhibitors
EA201691916A1 (ru) Биарильные ингибиторы киназы
MX2015011374A (es) Inhibidores de indolamina 2,3-dioxigenasa (ido).
MX2016002075A (es) Inhibidores de indolamina 2,3-dioxigenasa (ido).
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
MX366875B (es) Inhibidores de indoleamina 2,3-dioxigenasa (ido).
MX2015017486A (es) Inhibidores de indolamina 2,3-dioxigenasa (dio).
MY189454A (en) 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
EP4252851A3 (en) Ezh2 inhibitors for treating lymphoma
EA201691397A1 (ru) Хинолиновые ингибиторы киназы
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
MX2017013875A (es) Ciertos inhibidores de la proteína quinasa.
MX2017015923A (es) Inhibidores de indolamina-2,3-dioxigenasa (ido).
MX2018003301A (es) Inhibidores de pcna.
EA201691549A1 (ru) Ариллактамные ингибиторы киназы
MX2017011116A (es) Composiciones novedosas, usos y metodos para hacerlas.
TN2018000057A1 (en) Compounds useful for inhibiting ror-gamma-t.
MX2016009655A (es) Metodos novedosos para el tratamiento del cancer.
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
MX2017013729A (es) Deteccion especifica de isoformas de clusterina.